Please login to the form below

Not currently logged in
Email:
Password:

rights

This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.

With Spiriva under pressure, Boehringer moves to bolster pipeline

With Spiriva under pressure, Boehringer moves to bolster pipeline

The deal includes an upfront payment of $26m, plus $200m in milestones, for rights to a lymphatic-targeting technology that Boehringer will use alongside one of its own immuno-oncology candidates.

Latest news

  • EU files WTO dispute with Turkey over pharma laws EU files WTO dispute with Turkey over pharma laws

    In addition, Turkey is insisting on various technology transfer requirements for foreign companies that elect to move production to the country that amount to a violation of intellectual property rights.

  • Alnylam swaps Sanofi for Regeneron as R&D partner Alnylam swaps Sanofi for Regeneron as R&D partner

    For the CNS programmes, the intention is to allocate a lead company for each asset so that Regeneron and Alnylam alternate when it comes to development and commercial rights. ... Alnylam's John Maraganore. “The alliance structure enables Alnylam to

  • Amazon launches first Alexa health services Amazon launches first Alexa health services

    In particular, we believe voice technology, like Alexa, can make it easy for people stay on the right path by tracking the status of their mail order prescription, helping us further

  • Novartis and Amgen come to blows over migraine partnership Novartis and Amgen come to blows over migraine partnership

    Amgen has filed a lawsuit accusing Novartis of breaching their partnership for CGRP inhibitor Aimovig (erenumab) and seeking to terminate their 2015 contract, which gives Novartis co-marketing rights in the ... deal was first signed, and accuses Amgen of

  • Janssen’s CAR-T gains PRIME status in Europe Janssen’s CAR-T gains PRIME status in Europe

    Its investigational B-cell maturation antigen (BCMA) CAR-T therapy is named JNJ-68284528 (JNJ-4528), which the company acquired rights to when it signed a co-development deal with Chinese

More from news
Approximately 2 fully matching, plus 2,233 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 458 partially matching documents found.

Latest appointments

  • Streaming Well to “raise the bar in pharma film making” Streaming Well to “raise the bar in pharma film making”

    Steve Skinner (pictured right) joins Streaming Well as the company’s new Creative Director.

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    management team with the right scientific and leadership expertise to move the organisation forward”.

  • Weekly industry appointments Weekly industry appointments

    Gelesis adds to company. Biotech Gelesis has bolstered its offering with the addition of Harry Leider (pictured top right), former chief medical officer and group vice president of pharmacy company Walgreens. ... Also joining the company is Boehringer

  • Weekly comms appointments Weekly comms appointments

    Sarah Winterbottom joins ROAD. Independent healthcare communications specialist ROAD has appointed Sarah Winterbottom (pictured right) as senior director. ... W2O appoints Ujwal Pyati. W2O, a network of analytics-driven, digital marketing communications

  • Novartis changes executive committee Novartis changes executive committee

    Narasimhan, said: “Robert’s deep understanding of business services coupled with his strong financial and commercial acumen make him the right person to lead NBS in the next stage of its

More from appointments
Approximately 0 fully matching, plus 235 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 406 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics